Skip to content

Joel Gelernter

7 papers in the library · 147 citations · publishing 2004-2026

Papers

Sort Most recent Most cited

The stuff that dreams are made of: Genomics and biology of nightmares

medRxiv October 19, 2026 Joel Gelernter, Jack Hirsch, Cassie M. Overstreet et al. preprint

Frequent nightmares affect roughly 2-6% of the population and may reflect underlying psychopathology, such as post-traumatic stress disorder (PTSD), or, when recurrent and distressing, be diagnosed as nightmare disorder (ND). The genetic basis of nightmares remains poorly understood. We performed a genome-wide association study (GWAS) meta-analysis of nightmare frequency (NF) across 207,243...

769. Can the genetic of liver enzyme involved in THC metabolism tell us who are the cannabis users at greater risk of psychosis?

The International Journal of Neuropsychopharmacology September 9, 2026 Marta Di Forti, Isabelle Austin-Zimmerman, Edoardo Spinazzola et al.

Abstract Background Epidemiological data have consistently shown an association between heavy cannabis use and increased risk of psychotic disorders. Nevertheless, not all cannabis users develop the illness. Evidence from other substance of abuse such as Alcohol suggest how genetic differences in enzymes involved in its metabolism influence individual response to the drug. No studies to data...

Genetic Pathways Point to the Biology Underlying the Association Between Cannabis Use Disorder and Psychosis

Biological Psychiatry Global Open Science May 13, 2026 Isabelle Austin-Zimmerman, Qiang Li, E. Johnson et al.

Background Cannabis use is associated with increased risk of psychotic disorders, but the underlying biological mechanisms remain unclear. We used genetic data to investigate the molecular pathways contributing to the association between cannabis use disorder (CUD) and psychosis. Methods We conducted a cross-disorder meta-analysis of genome-wide association studies (GWASs) on schizophrenia and...

A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans

Translational Psychiatry November 18, 2019 Zhongshan Cheng, Chureerat Phokaew, Yi-Ling Chou et al. 4 citations

Abstract Cannabis, the most widely used illicit drug, can induce hallucinations. Our understanding of the biology of cannabis-induced hallucinations (Ca-HL) is limited. We used the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA) to identify cannabis-induced hallucinations (Ca-HL) among long-term cannabis users (used cannabis ≥1 year and ≥100 times). A genome-wide...

DOI: 10.1038/s41398-019-0639-7 (opens in new tab) Full text (opens in new tab) Cannabis Genome-wide association study Meta-analysis Single-nucleotide polymorphism +3

Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP).

Drug and Alcohol Dependence October 1, 2005 Joseph F Cubells, Richard Feinn, Deborah Pearson et al.

Cocaine can induce transient psychotic symptoms. We examined the phenomenology of such cocaine-induced psychosis (CIP) using a modified version of the Scale for Assessment of Positive Symptoms (SAPS), a well-validated instrument for the assessment of schizophrenic psychosis. We developed a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP),...

Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism

American Journal of Psychiatry October 1, 2004 Ismene L. Petrakis, Diana Limoncelli, Ralitza Gueorguieva et al. 143 citations

OBJECTIVE: A family history of alcoholism is a risk factor for the development of ethanol dependence. Ethanol is an antagonist of the N-methyl-d-aspartate (NMDA) glutamate receptor, and alterations in NMDA receptor function are thought to be involved in ethanol abuse and dependence. The purpose of this study was to determine in healthy individuals with no ethanol dependence whether response to...

DOI: 10.1176/ajp.161.10.1776 (opens in new tab) Nmda receptor Glutamate receptor Antagonist Vulnerability computing +2

Genomic Variation Predicts Real-Time Δ 9 -tetrahydrocannabinol Response in Humans

Uri Bright, Suhas Ganesh, Daniel F. Levey et al.

Abstract Background Cannabis is one of the most widely used psychoactive substances worldwide. Δ 9 -tetrahydrocannabinol (Δ 9 -THC) is the main contributor to cannabis-induced effects such as euphoria, anxiety, and psychotomimetic effects, and is metabolized by several hepatic enzymes, including CYP3A4. There are interindividual differences in how cannabis affects users, which have substantial...